Leaching from packaging prompts recall

Novartis is recalling physician samples of medications used to treat hypertension and cholesterol because of contamination from a chemical used in packaging.

The FDA issued a Class II recall on physician sample bottles of the blood pressure pharmaceuticals Diovan (valsartan), Exforge (amlodipine and valsartan) and Tekturna (aliskiren) because tests showed the presence of a photocuring agent in the tablets.

The agent, Darocur 1173, is used in inks on shrink-wrap sleeves.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup